Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion

Tumor suppressor function can be modulated by subtle variation of expression levels, proper cellular compartmentalization and post-translational modifications, such as phosphorylation, acetylation and sumoylation. The non-genomic loss of function of tumor suppressors offers a challenging therapeutic opportunity. The reactivation of a tumor suppressor could indeed promote selective apoptosis of cancer cells without affecting normal cells. The identification of mechanisms that affect tumor suppressor functions is therefore essential. In this work, we show that BCR-ABL promotes the accumulation of the NFKBIA gene product, I kappa B alpha, in the cytosol through physical interaction and stabilization of the protein. Furthermore, BCR-ABL/I kappa B alpha complex acts as a scaffold protein favoring p53 nuclear exclusion. We therefore identify a novel BCR-ABL/I kappa B alpha/p53 network, whereby BCR-ABL functionally inactivates a key tumor suppressor.